Issue of Equity

Toumaz Limited

Exercise of options and issue of equity

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Company'), a pioneer in low cost, ultra low power wireless communications technology, announces that following an exercise of options by a former employee over 1,137,000 ordinary shares of 0.25p in Toumaz,  the Company has applied for 1,137,000 new ordinary shares to be admitted to trading on AIM on 27 August 2010. Following the admission to trading of these new shares, Toumaz will have a total issued share capital of 593,624,726 Ordinary Shares.

The above figure of 593,624,726 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

Enquiries:

About Toumaz (www.toumaz.com)

Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

Targeting the Healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in real-time wireless monitoring of the body's vital signs. Sensium has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.

Toumaz also uses its ultra low power expertise to design devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to leaders in the digital radio market, such as PURE.

Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford, UK and Taipei City, Taiwan.